Engineered CRISPR-Cas12a for higher-order combinatorial chromatin perturbations.
C C-S HsiungC M WilsonN A SamboldR DaiQ ChenN TeyssierS MisiukiewiczAbolfazl ArabThomas A O'LoughlinJoshua C CofskyJunwei ShiLuke A GilbertPublished in: Nature biotechnology (2024)
Multiplexed genetic perturbations are critical for testing functional interactions among coding or non-coding genetic elements. Compared to double-stranded DNA cutting, repressive chromatin formation using CRISPR interference (CRISPRi) avoids genotoxicity and is more effective for perturbing non-coding regulatory elements in pooled assays. However, current CRISPRi pooled screening approaches are limited to targeting one to three genomic sites per cell. We engineer an Acidaminococcus Cas12a (AsCas12a) variant, multiplexed transcriptional interference AsCas12a (multiAsCas12a), that incorporates R1226A, a mutation that stabilizes the ribonucleoprotein-DNA complex via DNA nicking. The multiAsCas12a-KRAB fusion improves CRISPRi activity over DNase-dead AsCas12a-KRAB fusions, often rescuing the activities of lentivirally delivered CRISPR RNAs (crRNA) that are inactive when used with the latter. multiAsCas12a-KRAB supports CRISPRi using 6-plex crRNA arrays in high-throughput pooled screens. Using multiAsCas12a-KRAB, we discover enhancer elements and dissect the combinatorial function of cis-regulatory elements in human cells. These results instantiate a group testing framework for efficiently surveying numerous combinations of chromatin perturbations for biological discovery and engineering.
Keyphrases
- genome wide
- crispr cas
- high throughput
- transcription factor
- genome editing
- single cell
- circulating tumor
- copy number
- dna methylation
- gene expression
- cell free
- single molecule
- dna damage
- nucleic acid
- small molecule
- stem cells
- phase iii
- circulating tumor cells
- randomized controlled trial
- study protocol
- mesenchymal stem cells